Healthcare Headlines: From West Bank Violence to Overdose Decline

The World Health Organization raises alarms over increased West Bank violence affecting healthcare. In Congo, over 50 die due to unidentified illnesses. Hims & Hers faces Wall Street pressure on drug forecasts. Merck anticipates Keytruda price regulations. U.S. drug overdoses drop significantly. Trump signs an order enhancing healthcare price transparency.

The World Health Organization (WHO) has expressed deep concern about escalating violence in the Israeli-occupied West Bank, citing its impact on healthcare services. This comes after Israel deployed tanks to the area for the first time in over two decades, intending to combat Palestinian militant groups in local refugee camps.

In the Democratic Republic of Congo, the WHO reports more than 50 deaths linked to two clusters of an unknown illness. The outbreaks, occurring in separate villages of the Equateur province, have raised alarms, as the country continues to investigate the mysterious cause behind these cases.

Meanwhile, healthcare business landscapes are shifting as Hims & Hers Health faces plummeting shares due to concerns over future sales forecasts, while Merck braces for government price setting on its Keytruda cancer therapy in 2026. On a positive note, the U.S. witnesses a decline in drug overdose deaths, the lowest since June 2020, according to CDC data.